Matches in SemOpenAlex for { <https://semopenalex.org/work/W2058498478> ?p ?o ?g. }
Showing items 1 to 86 of
86
with 100 items per page.
- W2058498478 endingPage "728" @default.
- W2058498478 startingPage "716" @default.
- W2058498478 abstract "The objective of this work is to use a computer simulation approach to define the most sensitive analyte for in vivo bioequivalence studies of all types of Biopharmaceutics Classification System (BCS) drugs undergoing first-pass hepatic metabolism with two metabolic pathways. A semi-physiological model was developed in NONMEM VI to simulate bioequivalence trials. Four BCS classes (from Class I to IV) of drugs, with three possible saturation scenarios (non-saturation, saturation and saturation of only the major route of metabolism), two (high or low) dose schemes, and six types of pharmaceutical quality for the drug products were simulated. The number of investigated scenarios was 144 (4 × 3 × 2 × 6). The parent drug is the most sensitive analyte for bioequivalence trials in all the studied scenarios. Metabolite data does not show sensitivity to detect differences in pharmaceutical quality or it gives the same information as the parent compound. An interesting point to notice is the case of class I drugs administered at a high dose when the principal metabolic route is saturated and the secondary one is not saturated. In this case a substantial reduction in dissolution rate (as it could occur in the case of a prolonged release formulation developed as a line extension of an immediate release formulation) leads to a considerable increase in the AUC of the major metabolite whose formation is saturated supporting the need to require pharmacokinetic and clinical data for new prolonged release medicinal products." @default.
- W2058498478 created "2016-06-24" @default.
- W2058498478 creator A5014550963 @default.
- W2058498478 creator A5031225531 @default.
- W2058498478 creator A5043905754 @default.
- W2058498478 creator A5056679552 @default.
- W2058498478 creator A5060153224 @default.
- W2058498478 creator A5090638552 @default.
- W2058498478 date "2010-12-01" @default.
- W2058498478 modified "2023-10-16" @default.
- W2058498478 title "Computer simulations for bioequivalence trials: Selection of analyte in BCS drugs with first-pass metabolism and two metabolic pathways" @default.
- W2058498478 cites W1529022863 @default.
- W2058498478 cites W200484879 @default.
- W2058498478 cites W2024362305 @default.
- W2058498478 cites W2034048657 @default.
- W2058498478 cites W2074292089 @default.
- W2058498478 cites W2082436208 @default.
- W2058498478 cites W275565806 @default.
- W2058498478 cites W30211726 @default.
- W2058498478 cites W302445726 @default.
- W2058498478 cites W4248705730 @default.
- W2058498478 cites W4255293205 @default.
- W2058498478 doi "https://doi.org/10.1016/j.ejps.2010.09.017" @default.
- W2058498478 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20932901" @default.
- W2058498478 hasPublicationYear "2010" @default.
- W2058498478 type Work @default.
- W2058498478 sameAs 2058498478 @default.
- W2058498478 citedByCount "14" @default.
- W2058498478 countsByYear W20584984782012 @default.
- W2058498478 countsByYear W20584984782014 @default.
- W2058498478 countsByYear W20584984782015 @default.
- W2058498478 countsByYear W20584984782018 @default.
- W2058498478 countsByYear W20584984782020 @default.
- W2058498478 countsByYear W20584984782022 @default.
- W2058498478 countsByYear W20584984782023 @default.
- W2058498478 crossrefType "journal-article" @default.
- W2058498478 hasAuthorship W2058498478A5014550963 @default.
- W2058498478 hasAuthorship W2058498478A5031225531 @default.
- W2058498478 hasAuthorship W2058498478A5043905754 @default.
- W2058498478 hasAuthorship W2058498478A5056679552 @default.
- W2058498478 hasAuthorship W2058498478A5060153224 @default.
- W2058498478 hasAuthorship W2058498478A5090638552 @default.
- W2058498478 hasConcept C10390740 @default.
- W2058498478 hasConcept C112705442 @default.
- W2058498478 hasConcept C149151106 @default.
- W2058498478 hasConcept C185592680 @default.
- W2058498478 hasConcept C2777477808 @default.
- W2058498478 hasConcept C2780035454 @default.
- W2058498478 hasConcept C42404028 @default.
- W2058498478 hasConcept C43617362 @default.
- W2058498478 hasConcept C55493867 @default.
- W2058498478 hasConcept C71924100 @default.
- W2058498478 hasConcept C98274493 @default.
- W2058498478 hasConceptScore W2058498478C10390740 @default.
- W2058498478 hasConceptScore W2058498478C112705442 @default.
- W2058498478 hasConceptScore W2058498478C149151106 @default.
- W2058498478 hasConceptScore W2058498478C185592680 @default.
- W2058498478 hasConceptScore W2058498478C2777477808 @default.
- W2058498478 hasConceptScore W2058498478C2780035454 @default.
- W2058498478 hasConceptScore W2058498478C42404028 @default.
- W2058498478 hasConceptScore W2058498478C43617362 @default.
- W2058498478 hasConceptScore W2058498478C55493867 @default.
- W2058498478 hasConceptScore W2058498478C71924100 @default.
- W2058498478 hasConceptScore W2058498478C98274493 @default.
- W2058498478 hasIssue "5" @default.
- W2058498478 hasLocation W20584984781 @default.
- W2058498478 hasLocation W20584984782 @default.
- W2058498478 hasOpenAccess W2058498478 @default.
- W2058498478 hasPrimaryLocation W20584984781 @default.
- W2058498478 hasRelatedWork W1492229869 @default.
- W2058498478 hasRelatedWork W1964759623 @default.
- W2058498478 hasRelatedWork W1989480569 @default.
- W2058498478 hasRelatedWork W1998356222 @default.
- W2058498478 hasRelatedWork W2003476460 @default.
- W2058498478 hasRelatedWork W2014724304 @default.
- W2058498478 hasRelatedWork W2040155790 @default.
- W2058498478 hasRelatedWork W2056938528 @default.
- W2058498478 hasRelatedWork W2132691174 @default.
- W2058498478 hasRelatedWork W2141845144 @default.
- W2058498478 hasVolume "41" @default.
- W2058498478 isParatext "false" @default.
- W2058498478 isRetracted "false" @default.
- W2058498478 magId "2058498478" @default.
- W2058498478 workType "article" @default.